Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease | MicrobiomeTrials← Back to trialsNCT06325709
Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2024-04-17Est. Completion: 2032-12-31
Enrollment target: 10 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Chronic Granulomatous Disease (CGD)
Background:
X-Linked Chronic Granulomatous Disease (X-CGD) is caused by a gene mutation that makes the immune system to…
Bethesda, United StatesCompleted Sep 1, 2028
Chronic Granulomatous Disease
This study is a longitudinal and cross-sectional evaluation of patients with Chronic Granulomatous Disease (CGD) who rec…
Bethesda, United StatesCompleted Jun 2, 2022